The technique uses magnetic resonance imaging (MRI) to guide the insertion of a laser fibre into cancerous tumours. When heated, the laser destroys the cancerous tissue.
A follow-up study showed the potential to transfer this treatment for the first time into a clinic setting, using a special device (Artemis) that combines both MRI and ultrasound for real-time imaging.
If the laser technique, known as MRI-guided focal laser ablation, proves effective in further studies - especially using the new MRI-ultrasound fusion machine - it could improve treatment options and outcomes for men treated for such cancers, said Leonard Marks, a professor at the University of California, Los Angeles in the US.
"Our feeling was that if you can see prostate cancer using the fusion MRI and can put a needle in the spot to biopsy it, why not stick a laser fibre in the tumour the same way to kill it," Marks said.
"This is akin to a lumpectomy for breast cancer. Instead of removing the whole organ, target just the cancer inside it. What we are doing with prostate cancer now is like using a sledgehammer to kill a flea," he said.
The new study shows that MRI improves the ability of physicians to perform precise, laser-based treatment.
The new fusion-imaging method improves it even further, providing real-time ultrasound that more clearly delineates the tumour.
By combining laser ablation with this fusion-imaging technique, the potential of laser ablation grows enormously.
For the study, eight men underwent ablation while in an MRI machine.
Although none had serious side effects, longer-term follow-up is needed, as is a continued assessment of appropriate treatment margins to ensure cure, the researchers said.
"This focal therapy provides a middle ground for men to choose between radical prostatectomy and active surveillance, between doing nothing and losing the prostate," Marks said.
The study was published in the Journal of Urology.
